YLYan Li

Yan Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yan Li has a total of 57 co-authors. Here are the top co-authors by number of shared publications:

  • Chenyu Zhuang

    Yangzhou University School of Traditional Chinese Medicine, Faculty of Medicine Yangzhou

    5 shared publications
  • Bo Zhang

    Institute of Chinese Medicine, Heilongjiang University of Chinese Medicine, Harbin, China

    4 shared publications
  • Yanqing Liu

    Yangzhou University School of Traditional Chinese Medicine, Faculty of Medicine Yangzhou

    4 shared publications
  • Shu-Ming Huang

    Institute of Chinese Medicine, Heilongjiang University of Chinese Medicine, Harbin, China

    3 shared publications
  • Yifan Zhou

    Medical College, Yangzhou University, 225009 Yangzhou, PR China

    3 shared publications
  • Yuhan Cao

    Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou 225001, China

    3 shared publications

Latest Publications

  • The orexinergic system mediates the effects of ginsenoside Rg1 on cyclophosphamide-induced reproductive toxicity

    by Yan Li, Zixin Chang, Chenyu Zhuang, Shenfan Zhu, Jiong Hou, Tiantian Huang, Niuniu Yang, Haibo Wang, Yanqing Liu

    Cyclophosphamide (CP) is a widely prescribed chemotherapeutic and immunosuppressive agent known to cause significant reproductive toxicity. Ginseng effectively counteracts CP-induced reproductive toxicity, exhibiting pharmacological effects that resemble enhanced orexin signaling. In this study, molecular docking identified ginsenoside Rg1 as the candidate with the highest binding affinity for orexin receptor 1 (OX1R). In CP-treated male mice, Rg1 dose-dependently ameliorated reproductive toxicity, as evidenced by improved sexual behavior, sperm motility and DNA integrity, serum testosterone levels, and testicular histology. These protective effects were significantly attenuated by co-administration of the OX1R antagonist SB-334867. Notably, serum orexin-A levels did not differ significantly across all experimental groups, indicating that Rg1 acts directly on testicular OX1R rather than by elevating circulating orexin-A. Mechanistically, Rg1 restored testicular PI3K/AKT phosphorylation in an OX1R-dependent manner and preserved glucose transporter 3 and glucose transporter 8 immunoreactivity in germ cells. These findings demonstrate that Rg1 protects against CP-induced reproductive toxicity through OX1R-dependent activation of the PI3K/AKT pathway and maintenance of glucose transporter-mediated metabolism. Thus, OX1R represents a crucial mechanistic node and Rg1 is a promising adjunct therapy to mitigate chemotherapy-related male infertility.

  • Open Access

    Integrating Single-Cell and RNA Sequencing to Predict Glioma Prognosis Through Lactylation

    by Ruyi Shen, Yinan Chen, Yan Li, Zhijie Lin

    Gliomas are the most prevalent primary malignant neoplasms of the central nervous system, distinguished by their high recurrence rates and poor prognosis. Aerobic glycolysis in tumors generates excess lactate, which promotes lactylation, a post-translational modification (PTM). Although accumulating evidence implicates lactylation in glioma initiation and progression, previous lactylation-focused prognostic studies lacked single-cell resolution and broad validation, limiting their generalizability and clinical relevance. Single-cell and bulk RNA sequencing (RNA-seq) data were integrated to identify lactylation-enriched tumor cell populations and derive candidate genes. A risk model was developed using univariate Cox regression and the Least Absolute Shrinkage and Selection Operator (LASSO), and its predictive performance was validated in independent cohorts from the China Glioma Genome Atlas (CGGA). To improve clinical applicability, a nomogram integrating the risk score incorporating key clinical variables was constructed and externally validated. The risk groups showed distinct immune microenvironment profiles and differential drug sensitivity patterns. In this study, we established and validated a lactylation-related gene signature, with the derived risk score serving as a reliable prognostic biomarker for glioma. Furthermore, the model not only predicts overall survival (OS) but also exhibits the potential to inform drug selection and stratify patients for more precise and personalized therapeutic interventions.


  • Modeling Alzheimer’s disease in mice: Gonadectomy combined with bilateral hippocampus dentate gyrus injection of Aβ1-42 oligomers

    by Yan Li, Qian Gao, Chenyu Zhuang, Yifan Zhou, Zixin Chang, Yingying Zhao, Shenfan Zhu, Yanqing Liu, Bo Zhang


  • The orexin/hypocretin system in dementia-related neurological disorders: a double-edged sword in cognitive impairment

    by Chenyu Zhuang, Yuhan Cao, Jiayu Lu, Yifan Zhou, Yanqing Liu, Yan Li

    Rationale The orexin (OX) system plays a crucial role in regulating cognitive functions. Dysregulation of this system has been implicated in several dementia-related neurological disorders, including Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD) and dementia with Lewy bodies (DLB). Objectives This review aims to synthesize current research on the involvement of the OX system in dementia-related neurological diseases, focusing on its effects on cognitive function and its potential as a therapeutic target. Results The OX system, encompassing hypothalamic neuropeptides and receptors (OX1R and OX2R), exhibits dysregulation in neurodegenerative diseases associated with dementia. Changes in OX concentrations strongly correlate with cognitive decline, and this correlation varies with disease progression. OX regulates essential molecular mechanisms, including neuronal survival, synaptic plasticity, neural network integrity, and circadian rhythm stability—processes impaired as cognitive deficits intensify. These findings emphasize OX’s critical and context-dependent role in cellular resilience and cognitive function. Conclusions OX system emerges as a multifaceted therapeutic target for dementia-related cognitive impairment. Its effects vary across disease stages, initially offering neuroprotection but later contributing to pathology. Moreover, OX’s involvement in circadian rhythm regulation complicates its clinical utility, as disruptions exacerbate cognitive deficits. These opposing functions highlight the need for tailored, stage-specific interventions to maximize cognitive benefits while minimizing adverse signaling.


  • Open Access

    Compensatory enhancement of orexinergic system functionality induced by amyloid-β protein: a neuroprotective response in Alzheimer’s disease

    by Chenyu Zhuang, Hengyu Yan, Jiayu Lu, Yifan Zhou, Yanqing Liu, Guoshan Shi, Yan Li

    Background: Amyloid-β protein (Aβ) accumulation is a defining characteristic of Alzheimer’s disease (AD), resulting in neurodegeneration and a decline in cognitive function. Given orexin’s well-documented role in enhancing memory and cognition, this study investigates its potential to regulate Aβ-induced neurotoxicity, offering new perspectives into AD management.Methods: This paper simulated Aβ accumulation in the hippocampus of AD patients by administering Aβ1-42 oligomers into the bilateral hippocampal dentate gyrus of ICR mice. Inflammatory cytokines (IL-6, TNF-α) and orexin-A levels were measured by ELISA. Additionally, the excitability of orexinergic neurons was assessed by IHC targeting c-Fos expression. These methodologies evaluated the Aβ-induced neuroinflammation, orexinergic system functionality, and dexamethasone’s (Dex) effects on these processes.Results: Injection of Aβ1-42 oligomer resulted in elevated levels of IL-6, TNF-α, and orexin-A in the hippocampus, as well as increased excitability of orexinergic neurons in the lateral hypothalamus (LH). Dex treatment reduced neuroinflammation, causing a reduction in orexin-A levels and the excitability of orexinergic neurons.Conclusion: Aβ-induced neuroinflammation is accompanied by enhanced levels of orexin-A and orexinergic neuron excitability. These findings suggest that the enhanced functionality of the orexinergic system may become a compensatory neuroprotective mechanism to counteract neuroinflammation and enhance cognitive function.


  • Open Access

    Association of weekend warriors and other physical activity patterns with hypertension in NHANES 2007–2018

    by Yuhan Cao, Chenyu Zhuang, Yaojia Zhang, Caiyu Liu, Yan Li

    To accommodate the fast-paced nature of modern life, the “Weekend Warriors (WW)” has emerged as a novel physical activity (PA) indicator. This study aims to investigate the relationship between WW and other PA patterns with hypertension, thereby addressing a significant research gap. Data from 30,697 participants in the National Health and Nutrition Examination Survey conducted between 2007 and 2018 were analyzed. We employed multiple regression analyses to examine the relationships among WW, other PA patterns, PA duration, PA intensity, and hypertension, with data stratified by various characteristics. Results showed that compared to the inactive group, the insufficiently PA pattern (OR = 0.9, 95% CI 0.8, 1.0), the WW group (OR = 0.9, 95% CI 0.7, 1.1), and the regularly active group (OR = 0.8, 95% CI 0.8, 0.9) were all negatively associated with hypertension, with the WW group showing a trend towards a reduced prevalence of hypertension (P for trend < 0.01). This association was particularly evident among middle-aged and older adults aged 41–80 years. Additionally, total moderate-to-vigorous physical activity (MVPA) time, as well as moderate and vigorous PA intensity, showed “L”-shaped and “U”-shaped relationships with hypertension, with inflection points at 2640 MET minutes, 45%, and 62%, respectively. Our study provides insights for selecting suitable PA patterns but indicates the need for further research.


  • Open Access

    The orexinergic system mediates the excitatory effects of caffeine on the arousal and sympathetic activity

    by Yan Li, Zhixuan Guo, Chenxi Cai, Danni Liu, Yin Kang, Pengfei Liu


  • Open Access

    Kaixin-San improves Aβ-induced synaptic plasticity inhibition by affecting the expression of regulation proteins associated with postsynaptic AMPAR expression

    by Bo Zhang, Meng-Lu Wang, Shu-Ming Huang, Yu Cui, Yan Li

    Objective: To explore the mechanism underlying Kaixin-San (KXS) regulation of postsynaptic AMPA receptor (AMPAR) expression to mitigate toxic effects of the amyloid-β protein (Aβ).Methods: An animal model was established via intracerebroventricular injection of Aβ1–42. The Morris water maze test was conducted to evaluate learning and memory, while electrophysiological recording was conducted to assess the hippocampal long-term potentiation (LTP). Western blotting was used to detect expression levels of the hippocampal postsynaptic AMPAR and its accessory proteins.Results: The time spent to find the platform was significantly prolonged, the number of mice crossing the target site was significantly reduced, and the maintenance of LTP was inhibited in the Aβ group than in the control group. In the Aβ/KXS group, the time taken to find the platform was significantly shortened and the number of mice crossing the target site was significantly increased than in the Aβ group; furthermore, the inhibition of LTP induced by Aβ was reversed. The expression of GluR1, GluR2, ABP, GRIP1, NSF, and pGluR1–Ser845 was upregulated, while that of pGluR2–Ser880 and PKC δ was downregulated in the Aβ/KXS group.Conclusion: The increased expression of ABP, GRIP1, NSF, and pGluR1–Ser845 and the decreased expression of pGluR2–Ser880 and PKC δ under the influence of KXS, followed by the upregulation of postsynaptic GluR1 and GluR2, alleviated the inhibition of LTP induced by Aβ. Ultimately, the memory function of model animals was improved by KXS. Our study provides novel insights into the mechanism underlying KXS mitigation of Aβ-induced synaptic plasticity inhibition and memory impairment by altering the levels of accessory proteins associated with AMPAR expression.


  • Postsynaptic GluR2 Involved in Amelioration of Aβ-Induced Memory Dysfunction by KAIXIN-San Through Rescuing Hippocampal LTP in Mice

    by Bo Zhang, Yan Li, Jia-Wei Liu, Xue-Wei Liu, Wei Wen, Yu Cui, Shu-Ming Huang

    Kaixin-San (KXS), a Chinese formula, was used to treat “amnesia,” a senile dementia in the modern world. This formula was reported to improve behavioral performances in many animal models. This study was designed to explore how KXS has improved amyloid-β (Aβ)-induced memory dysfunction in mice. The mouse models were achieved through unilateral ventricle injection with Aβ 42 . The effects of KXS on memory improvement were evaluated by the step-down test. The electrophysiological changes induced by KXS were measured by long-term potentiation (LTP) analysis in the hippocampus in vivo . The expression of glutamate receptor 2 (GluR2) was observed through immunohistochemical staining. Behavioral experiment outcome demonstrated reduced avoidance time and increased error time during the step-down test in the mice of Aβ group. This memory impairment, however, was reversed by KXS. Electrophysiological experiment showed no significant difference between Aβ group and KXS group either in the size or the shape of field excitatory postsynaptic potentiation recorded from perforant path to dentate gyrus pathway. However, LTP in this region was reduced by Aβ and recovered by KXS administration. Moreover, immunohistochemical staining showed increased postsynaptic GluR2 expression in DG area in KXS group. These findings suggest that Aβ results in impairment to memory function of the animals, and KXS protects the animal from memory loss by rescuing LTP through postsynaptic mechanism which refers to increasing GluR2 expression.